Kathryn M. Edwards – författare

**Selected for Doody’s Core Titles� 2024 with "Essential Purchase" designation in Infectious Disease**From the latest vaccination evidence, recommendations, and protocols . . . to new vaccine development and the use of vaccines in reducing disease, Plotkin’s Vaccines, 8th Edition, covers every aspect of vaccination. Now completely revised and updated from cover to cover, this award-winning text continues to provide reliable information from global authorities, offering a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin’s Vaccines is a must-have reference for current, authoritative information in this fast-moving field.

**Selected for 2026 Doody's Core Titles as an Essential Purchase in Infectious Disease**A must-have reference for all clinicians who need comprehensive, in-depth advice and recommendations in this complex field, Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant, 9th Edition, provides expert coverage from the world’s leading authorities in immunology and infectious diseases. It offers the most up-to-date and complete guidance on infections found in utero, during delivery, and in the neonatal period in both premature and term infants-indispensable information for all clinicians who are involved in the care and well-being of these vulnerable patient populations. Three new associate editors and many new contributing authors bring new insight and a fresh perspective throughout the text.

What you should know about the Covid-19 vaccines from top experts in the field. As the SARS-Cov2 virus emerged and spread globally in early 2020, unprecedented international efforts began to develop and test vaccines to control the devastating pandemic. This book focuses on the remarkable progress in developing vaccines, the amazing effectiveness of the early vaccines, and the challenges of delivering them to the population. To put this extraordinary progress into perspective, the history of other vaccines is presented and their roles in individual protection and protection of the community, ';vaccines that protect the unvaccinated,' are outlined. The rigorous processes whereby vaccines are evaluated in distinct phases and the steps that must be met prior to obtaining regulatory approval for both vaccine safety and effectiveness are highlighted. Multiple vaccine approaches are reviewed, including new approaches such as ';messenger or mRNA vaccine' that may revolutionize future vaccine development. The comprehensive models used to provide recommendations and priorities for vaccination of groups of people at risk are summarized. The book also focuses on the questions that remain unanswered after the vaccines are approved. These include duration of immunity, risk factors for vaccine failure, impact of viral evolution and variant strains, and assessment of both immediate and long-term safety. The authors also address concerns about vaccine acceptance including roll-out, access, and detailed and trusted sources of information.